For Release: 11:00 am EST on October
19, 2007
Facet Solutions enjoys continued clinical success with
the Anatomic Facet Replacement System (AFRS™)
LOGAN, UTAH (October 19, 2007) – Facet Solutions, Inc.
announced today that John Regan, M.D., a board-certified orthopedic
surgeon at Century City Doctors Hospital in Los Angeles, California;
and Darryl DiRisio, M.D., associate professor and neurosurgeon
at Albany Medical College, Albany, New York; successfully completed
additional surgical procedures utilizing the company’s
Anatomic Facet Replacement System (AFRS™) as part of an
FDA approved IDE Clinical Trial.
The AFRS™ is the first anatomic facet joint replacement
device designed to provide patients with lumbar spinal stenosis
and facet degeneration a motion preserving alternative to fusion.
A fusion uses metal rods and screws to join vertebrae together.
While most patients report pain relief after a spinal fusion,
the surgery often eliminates flexibility and range of motion,
and can cause unnecessary wear on other spinal levels. By contrast,
the AFRS™ is designed to mimic normal motion and prevent
adjacent level degeneration.
The AFRS™ is made of two highly polished cobalt chrome
implants that articulate similar to other total joints that have
been used successfully in hip and knee replacements for several
decades
“
Until recently, people suffering from chronic low back and leg
pain caused by lumbar spinal stenosis had few treatment options,” stated
Dr. Regan. “Facet joint replacement utilizing the AFRS™ not
only relieves low back pain but also has the potential to significantly
improve the patients' flexibility and range of motion.
Dr. DiRisio noted that the use of facet joint replacement for
the treatment of lumbar spinal stenosis following a spinal decompression
is a notable advance in spinal surgery. "It offers surgeons
an alternative treatment for patients who have suffered for years
from this debilitating condition."
The public response overall to the AFRS™ clinical trial
has been very strong. New clinical investigator, Kenneth Pettine,
M.D., board-certified orthopedic surgeon with the Rocky Mountain
Spine Arthoplasty Specialists in Loveland, Colorado is looking
forward to offering this new treatment option to his patients.
“
Recently, I hosted a local community presentation to educate
patients on the advantages of this new technology,” stated
Dr. Pettine. “I was very pleased with the strong attendance
and was encouraged that a third of the attendees had signed up
to learn more about the AFRS™ trial. The potential for
patients to maintain motion, and continue with the normal activities
of daily living, is what I believe is driving the high level
of interest in this trial.”
Facet Solutions invites clinicians, medical facilities, and
other interested parties to visit www.facetsolutions.com for
specific information about the AFRS™ Clinical Trial.
Facet Solutions also invites patients who are interested in
learning more about the AFRS™ clinical trial to visit www.stenosisrelief.com.
To determine if they are eligible to participate in the trial,
patients can also call CLINICAL TRIAL RECUITING HAS CLOSED.
*Note: AFRS™ is an investigational device in the United
States. It is limited by United States (U.S.) Federal Law for
investigational use only.
About Facet Solutions
Facet Solutions, Inc. is a privately held, venture backed company
that is focused on developing and commercializing surgical devices
for the treatment of facet related spinal disorders. Facet Solutions
has received venture capital from its partners De Novo Ventures,
Pequot Ventures, and Spray Venture Partners. Facet Solutions
is FDA registered and is certified to ISO 13485.
# # #
Press Contact
Eric Olson
VP of Sales and Marketing
Facet Solutions, Inc.
435.753.1671 x-121
eolson@facetsolutions.com
|
